CTRI/2022/01/039094招募中2 期
Plasma Exchange in Acute on chronic Liver Failure: A Randomized Control Trial.
试验速览
- 阶段
- 2 期
- 状态
- 招募中
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Written informed consent.
- •2.18 – 60 years of age
- •3.EASL-ACLF grade 1 and 2
排除标准
- •1.Systolic blood pressure < 90 mm Hg
- •2.Lack of informed consent
- •3.Coexisting severe illness e.g., coronary artery disease, malignancy etc
- •4.Post Liver Transplant patients
- •5.Pregnancy
- •7.Active infection- bacterial or fungal.
- •8.Hepatocellular carcinoma
- •9.Patient who dies within 48 hrs of admission
研究者
相似试验
尚未招募
2 期
Role of High Volume Plasma Exchange in Acute Liver failure: Pilot Randomized Control TrialCTRI/2017/08/009525Department of Gastroenterology AIIMS New Delhi
招募中
不适用
Hemoabsorption in Acute-On-Chronic Liver FailureK72Hepatic failure, not elsewhere classifiedDRKS00033570niklinik RWTH Aachen10
Unknown
3 期
Plasma Exchange in Acute on Chronic Liver FailureCirrhosis, LiverAcute-On-Chronic Liver FailureNCT04051437Asian Institute of Gastroenterology, India130
进行中（未招募）
1 期
Biological mechanisms of Acute on Chronic Liver Failure (ACLF) and Mechanisms of Action of Plasma Exchange with Human Serum Albumin 5% in Subjects with cirrhosis with systemic inflammation and ACLFEUCTR2017-002677-19-ESInstituto Grifols S.A.250
进行中（未招募）
1 期
Biological mechanisms of Acute on Chronic Liver Failure (ACLF) and Mechanisms of Action of Plasma Exchange with Human Serum Albumin 5% in Subjects with cirrhosis with systemic inflammation and ACLFGroup 1 and 2:Subjects with cirrhosis with ACLF-1b, ACLF-2, or ACLF-3a detected either at admission or duringhospitalization Group 3: Subject with cirrhosis hospitalized for Acute decompensation of cirrhosis (ascites, hepatic encephalopathy [HE], gastrointestinal hemorrhage, and/or bacterial infections)MedDRA version: 20.1Level: LLTClassification code 10064704Term: Decompensated cirrhosisSystem Organ Class: 100000004871EUCTR2017-002677-19-DEInstituto Grifols S.A.250